Dew - to your comment: One more wildcard: it would not be completely shocking to see Pharming try to exploit this delay with a offer to buy GTCB
Actually, I was thinking exactly the same thing a bit earlier. At this price point, depending what else they're looking at in terms of partnership arrangements, etc., it would potentially be on the table.
As you stated - not likely, but definately a possibility.
Market Data 
Markets 
AI
